Modulators of liver receptor homologue 1 (LRH-1) and uses
US10843996B2 · kind B2 · utility
3Cited by
2References
12Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 16, 2018 |
| Grant date | Nov 24, 2020 |
| Priority date | — |
| Expiry date | Mar 16, 2038 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07C2602/22
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
This disclosure relates to modulators of liver receptor homologue 1 (LRH-1) and methods of managing disease and conditions related thereto. In certain embodiments, modulators are derivatives of hexahydropentalene. In certain embodiments, this disclosure relates to methods of treating or preventing cancer, diabetes, or cardiovascular disease by administering an effective amount of a hexahydropentalene derivative disclosed herein.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.